Klebsiella pneumoniae poses a growing global threat due to rising multidrug resistance and hypervirulence. This talk reviews current vaccine approaches, including glycoconjugates, protein antigens, and OMVs, alongside key translation challenges like antigenic diversity and preclinical models.
